"Medicare beneficiaries who undergo EBV present with fewer comorbidities, but after risk adjustment they have higher mortality and procedure-related morbidity than those undergoing LVRS," finds study of 3,219 patients comparing contemporary surgical outcomes.
"Freedom from re-intervention was 91% at 10 years and 87% at 20 years," reports long-term study of 252 patients who underwent Ross procedure for aortic valve disease.
Medicare analysis of 1M+ CABG procedures challenges conventional wisdom on multi-arterial grafting survival benefits when accounting for surgeon preference patterns.